2018-11-16T09:49:15Z
2018-11-16T09:49:15Z
2015
2018-07-24T12:35:22Z
Ornithine transcarbamylase deficiency (OTCD) is a rare X-linked disorder of urea synthesis leading to hyperammonemia. Several late-onset cases have been reported. Undiagnosed and untreated patients are at the risk of death or suffering from irreversible sequelae. We describe a 56-year-old patient who presented with acute encephalopathy after steroid treatment. Hyperammonemia due to OTCD was diagnosed and a mutation was found. This allowed us to diagnose two other family members with unexplained encephalopathy who are now asymptomatic on a low-protein diet. OTCD should be considered in any patient with hyperammonemic encephalopathy and immediate treatment should be given to avoid a fatal outcome. We emphasize the need to examine other family members if the diagnosis is confirmed, in order to prevent further life-threatening episodes of encephalopathy or neonatal coma of newborn.
Article
Published version
English
Malalties rares; Malalties cerebrals; Rare diseases; Brain diseases
Hindawi Ltd
Reproducció del document publicat a: https://doi.org/10.1155/2015/453752
Case Reports in Neurological Medicine, 2015, vol.
https://doi.org/10.1155/2015/453752
cc by (c) Gascón Bayarri et al., 2015
http://creativecommons.org/licenses/by/3.0/es/